Decera Clinical Insights
@deceraclinicalins.bsky.social
We’re becoming Decera Clinical Insights! Explore expert articles on #medicalresearch, new therapies, trials, and evolving #healthcare policy. Stay ahead with insights shaping patient care and clinical innovation. 👉 https://bit.ly/4fXEdUu
#MedSky #OncSky
#MedSky #OncSky
We can’t wait to debut our new look at #ASH25 👀✨
Meet Decera Clinical Insights (formerly CCS + MDOutlook) in person.
Find us at Booth 142.
Learn more: https://bit.ly/48xYxKN
#ASH2025 #MedicalInsights #MedicalStrategy #DeceraClinical
Meet Decera Clinical Insights (formerly CCS + MDOutlook) in person.
Find us at Booth 142.
Learn more: https://bit.ly/48xYxKN
#ASH2025 #MedicalInsights #MedicalStrategy #DeceraClinical
November 26, 2025 at 8:51 PM
We can’t wait to debut our new look at #ASH25 👀✨
Meet Decera Clinical Insights (formerly CCS + MDOutlook) in person.
Find us at Booth 142.
Learn more: https://bit.ly/48xYxKN
#ASH2025 #MedicalInsights #MedicalStrategy #DeceraClinical
Meet Decera Clinical Insights (formerly CCS + MDOutlook) in person.
Find us at Booth 142.
Learn more: https://bit.ly/48xYxKN
#ASH2025 #MedicalInsights #MedicalStrategy #DeceraClinical
We’re now Decera Clinical Insights (deh-SAIR-uh), formerly MDOutlook and CCS. Our name has evolved, but our trusted expertise, real-world data, and strategic intelligence remain the same. Thank you for celebrating this next chapter with us! Learn more: corporate.deceraclinical.com?utm_source=b...
November 21, 2025 at 7:40 PM
We’re now Decera Clinical Insights (deh-SAIR-uh), formerly MDOutlook and CCS. Our name has evolved, but our trusted expertise, real-world data, and strategic intelligence remain the same. Thank you for celebrating this next chapter with us! Learn more: corporate.deceraclinical.com?utm_source=b...
BIG NEWS! Clinical Care Solutions (CCS) is evolving into Decera Clinical Insights (deh-SAIR-uh) — a new name built for the future. Our look is changing, but your experience will stay the same. The same expert team, trusted science, and meaningful insights — now under one unified brand.
October 30, 2025 at 8:54 PM
BIG NEWS! Clinical Care Solutions (CCS) is evolving into Decera Clinical Insights (deh-SAIR-uh) — a new name built for the future. Our look is changing, but your experience will stay the same. The same expert team, trusted science, and meaningful insights — now under one unified brand.
🌍 In this Oncology Unscripted clip, Dr Marshall reflects on how shifting global regulatory landscapes may create opportunities to reduce drug development costs while keeping innovation at the forefront.
👉 Watch now: https://bit.ly/47vADio
#OncologyUnscripted #ESMO #Oncology #DrugDevelopment
👉 Watch now: https://bit.ly/47vADio
#OncologyUnscripted #ESMO #Oncology #DrugDevelopment
October 29, 2025 at 5:10 PM
🌍 In this Oncology Unscripted clip, Dr Marshall reflects on how shifting global regulatory landscapes may create opportunities to reduce drug development costs while keeping innovation at the forefront.
👉 Watch now: https://bit.ly/47vADio
#OncologyUnscripted #ESMO #Oncology #DrugDevelopment
👉 Watch now: https://bit.ly/47vADio
#OncologyUnscripted #ESMO #Oncology #DrugDevelopment
In the latest episode of #OncologyUnscripted, Dr. Marshall sits down with Dr. Powles to explore how MRD-positive disease represents its own unique biology, and why traditional regimens like FOLFOX may not be the right answer in this setting.
🎥 Watch: https://bit.ly/46Z51la
🎥 Watch: https://bit.ly/46Z51la
October 27, 2025 at 6:53 PM
In the latest episode of #OncologyUnscripted, Dr. Marshall sits down with Dr. Powles to explore how MRD-positive disease represents its own unique biology, and why traditional regimens like FOLFOX may not be the right answer in this setting.
🎥 Watch: https://bit.ly/46Z51la
🎥 Watch: https://bit.ly/46Z51la
“How do we treat smarter?” 💡 Dr Marshall sits down with genitourinary cancer expert Dr Thomas Powles to discuss how ctDNA and measurable residual disease (MRD) are reshaping patient selection for adjuvant therapy.
👉 Watch the full conversation: https://bit.ly/49aAeTV
👉 Watch the full conversation: https://bit.ly/49aAeTV
October 23, 2025 at 4:15 PM
“How do we treat smarter?” 💡 Dr Marshall sits down with genitourinary cancer expert Dr Thomas Powles to discuss how ctDNA and measurable residual disease (MRD) are reshaping patient selection for adjuvant therapy.
👉 Watch the full conversation: https://bit.ly/49aAeTV
👉 Watch the full conversation: https://bit.ly/49aAeTV
New Episode of #OncologyUnscripted! Explores key updates #ESMO25:
🔹 Emerging trends in precision oncology
🔹 The growing role of ctDNA in treatment strategies
🔹 China’s expanding influence in clinical research and oncology treatment .
👉 Watch the full video here: https://bit.ly/47vADio
🔹 Emerging trends in precision oncology
🔹 The growing role of ctDNA in treatment strategies
🔹 China’s expanding influence in clinical research and oncology treatment .
👉 Watch the full video here: https://bit.ly/47vADio
October 20, 2025 at 6:55 PM
New Episode of #OncologyUnscripted! Explores key updates #ESMO25:
🔹 Emerging trends in precision oncology
🔹 The growing role of ctDNA in treatment strategies
🔹 China’s expanding influence in clinical research and oncology treatment .
👉 Watch the full video here: https://bit.ly/47vADio
🔹 Emerging trends in precision oncology
🔹 The growing role of ctDNA in treatment strategies
🔹 China’s expanding influence in clinical research and oncology treatment .
👉 Watch the full video here: https://bit.ly/47vADio
In this moment, Dr. Marshall & Dr. Cannon dig into the why behind the link between ultramarathoners and higher rates of precancerous polyps. A closer look at how endurance training and lifestyle choices may unexpectedly influence cancer risk.
👉 Watch the full episode: https://bit.ly/4pzrfBz
👉 Watch the full episode: https://bit.ly/4pzrfBz
October 3, 2025 at 9:13 PM
In this moment, Dr. Marshall & Dr. Cannon dig into the why behind the link between ultramarathoners and higher rates of precancerous polyps. A closer look at how endurance training and lifestyle choices may unexpectedly influence cancer risk.
👉 Watch the full episode: https://bit.ly/4pzrfBz
👉 Watch the full episode: https://bit.ly/4pzrfBz
“If enough of us get out and scream… if enough of us rise up—we can take back our healthcare and our successes, so we don’t step backwards.” – Dr. @marshalj23
Watch the latest episode here: https://bit.ly/4259gZG
#OncologyUnscripted #CancerCare #VaccineAccess #PublicHealth
Watch the latest episode here: https://bit.ly/4259gZG
#OncologyUnscripted #CancerCare #VaccineAccess #PublicHealth
September 30, 2025 at 6:50 PM
“If enough of us get out and scream… if enough of us rise up—we can take back our healthcare and our successes, so we don’t step backwards.” – Dr. @marshalj23
Watch the latest episode here: https://bit.ly/4259gZG
#OncologyUnscripted #CancerCare #VaccineAccess #PublicHealth
Watch the latest episode here: https://bit.ly/4259gZG
#OncologyUnscripted #CancerCare #VaccineAccess #PublicHealth
🏃 Can too much exercise actually increase cancer risk? Dr. John Marshall sits down with Dr. Timothy Cannon to unpack surprising new data: ultramarathoners may face higher rates of precancerous polyps.
👉 Watch the full conversation: https://bit.ly/46f5yiA
#OncologyUnscripted #CancerCare #ColonCancer
👉 Watch the full conversation: https://bit.ly/46f5yiA
#OncologyUnscripted #CancerCare #ColonCancer
September 26, 2025 at 9:07 PM
🏃 Can too much exercise actually increase cancer risk? Dr. John Marshall sits down with Dr. Timothy Cannon to unpack surprising new data: ultramarathoners may face higher rates of precancerous polyps.
👉 Watch the full conversation: https://bit.ly/46f5yiA
#OncologyUnscripted #CancerCare #ColonCancer
👉 Watch the full conversation: https://bit.ly/46f5yiA
#OncologyUnscripted #CancerCare #ColonCancer
Vaccine access is unraveling, and cancer patients may be the first to suffer. Dr. John Marshall sounds the alarm on:
✔️ CDC disruptions ✔️ Anti-vaccine rhetoric ✔️ Shifts in vaccine policy
👉 Watch Episode 21 now: https://bit.ly/4259gZG
✔️ CDC disruptions ✔️ Anti-vaccine rhetoric ✔️ Shifts in vaccine policy
👉 Watch Episode 21 now: https://bit.ly/4259gZG
September 23, 2025 at 7:07 PM
Vaccine access is unraveling, and cancer patients may be the first to suffer. Dr. John Marshall sounds the alarm on:
✔️ CDC disruptions ✔️ Anti-vaccine rhetoric ✔️ Shifts in vaccine policy
👉 Watch Episode 21 now: https://bit.ly/4259gZG
✔️ CDC disruptions ✔️ Anti-vaccine rhetoric ✔️ Shifts in vaccine policy
👉 Watch Episode 21 now: https://bit.ly/4259gZG
#OncologyUnscripted is now streaming as a podcast! 🎙️ Wherever you listen, you can now access in-depth discussions on the evolving oncology landscape.
👉 Listen on Spotify: https://bit.ly/4niGP2i
👉 Listen on Apple: https://apple.co/3K9vfbw
👉 Listen on Spotify: https://bit.ly/4niGP2i
👉 Listen on Apple: https://apple.co/3K9vfbw
September 9, 2025 at 7:12 PM
#OncologyUnscripted is now streaming as a podcast! 🎙️ Wherever you listen, you can now access in-depth discussions on the evolving oncology landscape.
👉 Listen on Spotify: https://bit.ly/4niGP2i
👉 Listen on Apple: https://apple.co/3K9vfbw
👉 Listen on Spotify: https://bit.ly/4niGP2i
👉 Listen on Apple: https://apple.co/3K9vfbw
👀 More young, healthy adults—no family history, no genetic markers—are being diagnosed with colon cancer. Nearly 90% are rectosigmoid cases.
Why? The microbiome is one theory, but the cause remains unclear.
Watch #OncologyUnscripted with Dr. John Marshall: ▶️ https://bit.ly/3HMy0yQ
Why? The microbiome is one theory, but the cause remains unclear.
Watch #OncologyUnscripted with Dr. John Marshall: ▶️ https://bit.ly/3HMy0yQ
September 5, 2025 at 8:16 PM
👀 More young, healthy adults—no family history, no genetic markers—are being diagnosed with colon cancer. Nearly 90% are rectosigmoid cases.
Why? The microbiome is one theory, but the cause remains unclear.
Watch #OncologyUnscripted with Dr. John Marshall: ▶️ https://bit.ly/3HMy0yQ
Why? The microbiome is one theory, but the cause remains unclear.
Watch #OncologyUnscripted with Dr. John Marshall: ▶️ https://bit.ly/3HMy0yQ
Younger patients with colon cancer often report every side effect, while older patients rarely mention them at all. Dr Marshall sits down with patient Chad Leo and Dr. Thejas Jayakrishnan to discuss the rise of early-onset GI cancers, treatment challenges: https://bit.ly/45IFGtN
September 2, 2025 at 6:45 PM
Younger patients with colon cancer often report every side effect, while older patients rarely mention them at all. Dr Marshall sits down with patient Chad Leo and Dr. Thejas Jayakrishnan to discuss the rise of early-onset GI cancers, treatment challenges: https://bit.ly/45IFGtN
Younger patients with GI cancers face a unique set of challenges. In this #OncologyUnscripted episode Dr. Marshall explores why early onset GI cancers are not just the same disease at a younger age and why the medical community needs to better understand & address this trend. https://bit.ly/4oOQuPV
August 28, 2025 at 6:53 PM
Younger patients with GI cancers face a unique set of challenges. In this #OncologyUnscripted episode Dr. Marshall explores why early onset GI cancers are not just the same disease at a younger age and why the medical community needs to better understand & address this trend. https://bit.ly/4oOQuPV
Younger patients are being diagnosed with cancer at rising rates—especially GI cancers. In this #OncologyUnscripted episode, Dr John Marshall breaks down a new JAMA review on early-onset GI cancers.
▶️ Watch here: https://bit.ly/3HMy0yQ
▶️ Watch here: https://bit.ly/3HMy0yQ
August 25, 2025 at 6:56 PM
Younger patients are being diagnosed with cancer at rising rates—especially GI cancers. In this #OncologyUnscripted episode, Dr John Marshall breaks down a new JAMA review on early-onset GI cancers.
▶️ Watch here: https://bit.ly/3HMy0yQ
▶️ Watch here: https://bit.ly/3HMy0yQ
100% benefit rate, but not 100% access.
In this episode of #OncologyUnscripted, Dr. John Marshall breaks down how smarter cancer care means not just new innovations, but affordable, accessible treatment for all. clinicalcaresolutions.net/activities/o...
In this episode of #OncologyUnscripted, Dr. John Marshall breaks down how smarter cancer care means not just new innovations, but affordable, accessible treatment for all. clinicalcaresolutions.net/activities/o...
July 17, 2025 at 3:12 PM
100% benefit rate, but not 100% access.
In this episode of #OncologyUnscripted, Dr. John Marshall breaks down how smarter cancer care means not just new innovations, but affordable, accessible treatment for all. clinicalcaresolutions.net/activities/o...
In this episode of #OncologyUnscripted, Dr. John Marshall breaks down how smarter cancer care means not just new innovations, but affordable, accessible treatment for all. clinicalcaresolutions.net/activities/o...
In this powerful episode of From Lab Coats to Leadership, Dr. Marshall speaks with Dr. Lucile Adams-Campbell and two other trailblazing women in science about mentorship, representation, and the fight for equity in medicine. clinicalcaresolutions.net/content/dr-j...
April 17, 2025 at 1:31 PM
In this powerful episode of From Lab Coats to Leadership, Dr. Marshall speaks with Dr. Lucile Adams-Campbell and two other trailblazing women in science about mentorship, representation, and the fight for equity in medicine. clinicalcaresolutions.net/content/dr-j...
Our next episode of #OncologyUnscripted is dropping soon!
Trust us, you don’t want to miss this one...subscribe: pages.mycea.com/oncology-uns...
Trust us, you don’t want to miss this one...subscribe: pages.mycea.com/oncology-uns...
February 14, 2025 at 4:48 PM
Our next episode of #OncologyUnscripted is dropping soon!
Trust us, you don’t want to miss this one...subscribe: pages.mycea.com/oncology-uns...
Trust us, you don’t want to miss this one...subscribe: pages.mycea.com/oncology-uns...
Could the Inflation Reduction Act slow cancer drug development? John Newby, CEO of the Virginia Biotech Association, joins Dr Marshall to discuss its impact on biotech startups bringing life-saving innovations to patients.
Watch here: pages.mycea.com/oncology-uns...
#InflationReductionAct
Watch here: pages.mycea.com/oncology-uns...
#InflationReductionAct
January 29, 2025 at 3:34 PM
Could the Inflation Reduction Act slow cancer drug development? John Newby, CEO of the Virginia Biotech Association, joins Dr Marshall to discuss its impact on biotech startups bringing life-saving innovations to patients.
Watch here: pages.mycea.com/oncology-uns...
#InflationReductionAct
Watch here: pages.mycea.com/oncology-uns...
#InflationReductionAct
What’s REALLY happening in cancer care?
Not everything makes it into the journals—but we’ve got you covered.
Next Oncology Unscripted episode drops soon! Stay ahead of the curve. #OncologyUnscripted #CancerCare pages.mycea.com/oncology-uns...
Not everything makes it into the journals—but we’ve got you covered.
Next Oncology Unscripted episode drops soon! Stay ahead of the curve. #OncologyUnscripted #CancerCare pages.mycea.com/oncology-uns...
January 27, 2025 at 3:07 PM
What’s REALLY happening in cancer care?
Not everything makes it into the journals—but we’ve got you covered.
Next Oncology Unscripted episode drops soon! Stay ahead of the curve. #OncologyUnscripted #CancerCare pages.mycea.com/oncology-uns...
Not everything makes it into the journals—but we’ve got you covered.
Next Oncology Unscripted episode drops soon! Stay ahead of the curve. #OncologyUnscripted #CancerCare pages.mycea.com/oncology-uns...
Pancreatic cancer research is advancing! 💜 New data shows up to 50% of patients responding to RAS inhibitors and immunotherapy combos. Now it’s time to integrate these breakthroughs and improve outcomes! pages.mycea.com/oncology-uns...
#PancreaticCancer #MedicalEducation
#PancreaticCancer #MedicalEducation
January 21, 2025 at 4:11 PM
Pancreatic cancer research is advancing! 💜 New data shows up to 50% of patients responding to RAS inhibitors and immunotherapy combos. Now it’s time to integrate these breakthroughs and improve outcomes! pages.mycea.com/oncology-uns...
#PancreaticCancer #MedicalEducation
#PancreaticCancer #MedicalEducation